Vanguard Fiduciary Trust
GOSS icon

Vanguard Fiduciary Trust’s Gossamer Bio GOSS Stock Holding History

Vanguard Fiduciary Trust’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$205K Sell
15,567
-1,987
-11% -$44.4K ﹤0.01% 3569
2026
Q1 		$462K Buy
+17,554
New +$2.21M ﹤0.01% 3235

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM

Vanguard Fiduciary Trust's GOSS Position: Q2 2026 in Review

Vanguard Fiduciary Trust reduced its Gossamer Bio (GOSS) stake by 11% in Q2 2026, selling an estimated $44.4K and leaving 15,567 shares worth $205K. The position accounts for ﹤0.01% of the portfolio, ranked #3569.

Vanguard Fiduciary Trust first reported a position in GOSS in Q1 2026 and has held it in 2 quarters since. The position peaked at $462K in Q1 2026. 166 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Vanguard Fiduciary Trust held 15,567 shares of Gossamer Bio worth $205K as of Q2 2026.
  • Vanguard Fiduciary Trust sold 1,987 Gossamer Bio shares in Q2 2026, an estimated $44.4K.
  • Gossamer Bio made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3569 holding.
  • Vanguard Fiduciary Trust first reported a position in Gossamer Bio in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Fiduciary Trust's Gossamer Bio position peaked at $462K in Q1 2026.
  • 166 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.